{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:08:52Z","timestamp":1790060932244,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","award":["Minist\u00e9rio da Sa\u00fade"],"award-info":[{"award-number":["Minist\u00e9rio da Sa\u00fade"]}],"id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11096-023-01637-2","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:01:43Z","timestamp":1694768503000},"page":"1037-1049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacists\u2019 contribution to benzodiazepine deprescribing in older outpatients: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"45","author":[{"given":"Thiago Afonso Rodrigues","family":"Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleyton Oliveira","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Br\u00edgida Dias","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inajara","family":"Rotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walleri Christini Torelli","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-4533","authenticated-orcid":false,"given":"Patricia Melo","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"issue":"4","key":"1637_CR1","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.sapharm.2021.06.025","volume":"18","author":"M McCarthy","year":"2022","unstructured":"McCarthy M, Mak S, Kaufmann CN, et al. Care coordination needs for deprescribing benzodiazepines and benzodiazepine receptor agonists. Res Social Adm Pharm. 2022;18(4):2691\u20134. https:\/\/doi.org\/10.1016\/j.sapharm.2021.06.025.","journal-title":"Res Social Adm Pharm"},{"key":"1637_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.11606\/s1518-8787.2022056003740","volume":"56","author":"MBO Freire","year":"2022","unstructured":"Freire MBO, Da Silva BGC, Bertoldi AD, et al. Benzodiazepines utilization in Brazilian older adults: a population-based study. Rev Saude Publica. 2022;56:10. https:\/\/doi.org\/10.11606\/s1518-8787.2022056003740.","journal-title":"Rev Saude Publica"},{"issue":"2","key":"1637_CR3","doi-asserted-by":"publisher","first-page":"20150079","DOI":"10.1098\/rsfs.2015.0079","volume":"6","author":"JH van Beek","year":"2016","unstructured":"van Beek JH, Kirkwood TB, Bassingthwaighte JB, et al. Understanding the physiology of the ageing individual: computational modelling of changes in metabolism and endurance. Interface Focus. 2016;6(2):20150079. https:\/\/doi.org\/10.1098\/rsfs.2015.0079.","journal-title":"Interface Focus."},{"issue":"10","key":"1637_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11920-016-0727-9","volume":"18","author":"G Airagnes","year":"2016","unstructured":"Airagnes G, Pelissolo A, Lavall\u00e9e M, et al. Benzodiazepine misuse in the elderly: risk factors, consequences, and management. Curr Psych Rep. 2016;18(10):89. https:\/\/doi.org\/10.1007\/s11920-016-0727-9.","journal-title":"Curr Psych Rep"},{"issue":"4","key":"1637_CR5","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1590\/1413-81232015214.10292015","volume":"21","author":"DC Naloto","year":"2016","unstructured":"Naloto DC, Lopes FC, Barberato Filho S, et al. Prescription of benzodiazepines for adults and older adults from a mental health clinic. Cien Saude Colet. 2016;21(4):1267\u201376. https:\/\/doi.org\/10.1590\/1413-81232015214.10292015.","journal-title":"Cien Saude Colet"},{"issue":"4","key":"1637_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"DM Fick","year":"2019","unstructured":"Fick DM, Semla TP, Steinman M, et al. American geriatrics society 2019 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u201394. https:\/\/doi.org\/10.1111\/jgs.15767.","journal-title":"J Am Geriatr Soc"},{"key":"1637_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fnagi.2019.00344","volume":"11","author":"M Ettcheto","year":"2020","unstructured":"Ettcheto M, Olloquequi J, S\u00e1nchez-L\u00f3pez E, et al. Benzodiazepines and related drugs as a risk factor in Alzheimer\u2019s disease dementia. Front Aging Neurosci. 2020;11:344. https:\/\/doi.org\/10.3389\/fnagi.2019.00344.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"1637_CR8","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/bcp.12386","volume":"78","author":"E Reeve","year":"2014","unstructured":"Reeve E, Shakib S, Hendrix I, et al. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738\u201347. https:\/\/doi.org\/10.1111\/bcp.12386.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1637_CR9","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1016\/j.sapharm.2021.07.012","volume":"18","author":"JD Niznik","year":"2022","unstructured":"Niznik JD, Collins BJ, Armistead LT, et al. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: a rapid review. Res Social Adm Pharm. 2022;18(6):2913\u201321. https:\/\/doi.org\/10.1016\/j.sapharm.2021.07.012.","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"1637_CR10","first-page":"339","volume":"64","author":"K Pottie","year":"2018","unstructured":"Pottie K, Thompson W, Davies S, et al. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339\u201351.","journal-title":"Can Fam Physician"},{"issue":"4","key":"1637_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40266-018-0536-4","volume":"35","author":"J Thillainadesan","year":"2018","unstructured":"Thillainadesan J, Gnjidic D, Green S, et al. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials. Drugs Aging. 2018;35(4):303\u201319. https:\/\/doi.org\/10.1007\/s40266-018-0536-4.","journal-title":"Drugs Aging"},{"issue":"2","key":"1637_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/bcp.14947","volume":"88","author":"I Bu\u017ean\u010di\u0107","year":"2022","unstructured":"Bu\u017ean\u010di\u0107 I, Kummer I, Dr\u017eai\u0107 M, et al. Community-based pharmacists\u2019 role in deprescribing: a systematic review. Br J Clin Pharmacol. 2022;88(2):452\u201363. https:\/\/doi.org\/10.1111\/bcp.14947.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1637_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12877-021-02208-8","volume":"21","author":"K Ibrahim","year":"2021","unstructured":"Ibrahim K, Cox NJ, Stevenson JM, et al. A systematic review of the evidence for deprescribing interventions among older people living with frailty. BMC Geriatr. 2021;21(1):258. https:\/\/doi.org\/10.1186\/s12877-021-02208-8.","journal-title":"BMC Geriatr"},{"key":"1637_CR14","unstructured":"Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org\/handbook"},{"key":"1637_CR15","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1136\/bmj.n71","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"Int J Surg"},{"issue":"1","key":"1637_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"1637_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8742998","author":"SB Dagnew","year":"2022","unstructured":"Dagnew SB, Binega Mekonnen G, Gebeye Zeleke E, et al. Clinical pharmacist intervention on drug-related problems among elderly patients admitted to medical wards of northwest Ethiopia comprehensive specialized hospitals: a multicenter prospective Observational Study. Biomed Res Int. 2022. https:\/\/doi.org\/10.1155\/2022\/8742998.","journal-title":"Biomed Res Int"},{"key":"1637_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604.ch8","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ, et al. Assessing risk of bias in a randomized trial. Cochrane Handb Syst Rev Interv. 2019. https:\/\/doi.org\/10.1002\/9781119536604.ch8.","journal-title":"Cochrane Handb Syst Rev Interv"},{"issue":"4","key":"1637_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Sch\u00fcnemann HJ, et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380\u20132. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.09.011.","journal-title":"J Clin Epidemiol"},{"key":"1637_CR20","unstructured":"Sch\u00fcnemann H, Brozek J, Guyatt G, et al, editors (The GRADE Working Group) (2013) GRADE handbook for grading quality of evidence and strength of recommendations. Available from: http:\/\/www.guidelinedevelopment.org\/handbook. Accessed 12 Jan 2023."},{"issue":"1","key":"1637_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1164","volume":"7","author":"AA Veroniki","year":"2016","unstructured":"Veroniki AA, Jackson D, Viechtbauer W, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods. 2016;7(1):55\u201379. https:\/\/doi.org\/10.1002\/jrsm.1164.","journal-title":"Res Synth Methods"},{"issue":"3","key":"1637_CR22","doi-asserted-by":"publisher","first-page":"e8164","DOI":"10.5867\/medwave.2021.03.8164","volume":"21","author":"B Schuller-Mart\u00ednez","year":"2021","unstructured":"Schuller-Mart\u00ednez B, Meza N, P\u00e9rez-Bracchiglione J, et al. Graphical representation of the body of the evidence: the essentials for understanding the evidence gap map approach. Medwave. 2021;21(3):e8164. https:\/\/doi.org\/10.5867\/medwave.2021.03.8164.","journal-title":"Medwave"},{"issue":"1","key":"1637_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12875-021-01415-x","volume":"22","author":"N Ashworth","year":"2021","unstructured":"Ashworth N, Kain N, Wiebe D, et al. Reducing prescribing of benzodiazepines in older adults: a comparison of four physician-focused interventions by a medical regulatory authority. BMC Fam Pract. 2021;22(1):68. https:\/\/doi.org\/10.1186\/s12875-021-01415-x.","journal-title":"BMC Fam Pract"},{"issue":"12","key":"1637_CR24","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1111\/jgs.16751","volume":"68","author":"P Evrard","year":"2020","unstructured":"Evrard P, Henrard S, Foulon V, et al. Benzodiazepine use and Deprescribing in Belgian nursing homes: results from the COME-ON study. J Am Geriatr Soc. 2020;68(12):2768\u201377. https:\/\/doi.org\/10.1111\/jgs.16751.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"1637_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4140\/TCP.n.2018.711","volume":"33","author":"HJ Navy","year":"2018","unstructured":"Navy HJ, Weffald L, Delate T, et al. Clinical pharmacist intervention to engage older adults in reducing use of alprazolam. Consult Pharm. 2018;33(12):711\u201322. https:\/\/doi.org\/10.4140\/TCP.n.2018.711.","journal-title":"Consult Pharm"},{"issue":"3","key":"1637_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1365-2125.2001.00347.x","volume":"51","author":"MS Roberts","year":"2001","unstructured":"Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51(3):257\u201365. https:\/\/doi.org\/10.1046\/j.1365-2125.2001.00347.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1637_CR27","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","volume":"174","author":"C Tannenbaum","year":"2014","unstructured":"Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890\u20138. https:\/\/doi.org\/10.1001\/jamainternmed.2014.949.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1637_CR28","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.sapharm.2021.06.023","volume":"18","author":"C Hern\u00e1ndez-Prats","year":"2022","unstructured":"Hern\u00e1ndez-Prats C, L\u00f3pez-Pintor E, Lumbreras B, et al. Pharmacist-led intervention on the reduction of inappropriate medication use in patients with heart failure: a systematic review of randomized trials and non-randomized intervention studies. Res Social Adm Pharm. 2022;18(5):2748\u201356. https:\/\/doi.org\/10.1016\/j.sapharm.2021.06.023.","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"1637_CR29","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s11096-020-01073-6","volume":"42","author":"C Balsom","year":"2020","unstructured":"Balsom C, Pittman N, King R, et al. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial. Int J Clin Pharm. 2020;42(4):1153\u201367. https:\/\/doi.org\/10.1007\/s11096-020-01073-6.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"1637_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jamda.2020.03.012","volume":"22","author":"CH Kua","year":"2021","unstructured":"Kua CH, Yeo CYY, Tan PC, et al. Association of deprescribing with reduction in mortality and hospitalization: a pragmatic stepped-wedge cluster-randomized controlled trial. J Am Med Dir Assoc. 2021;22(1):82\u20139. https:\/\/doi.org\/10.1016\/j.jamda.2020.03.012.","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"1637_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/17151635211014918","volume":"154","author":"E Lui","year":"2021","unstructured":"Lui E, Wintemute K, Muraca M, et al. Pharmacist-led sedative-hypnotic deprescribing in team-based primary care practice. Can Pharm J Ott. 2021;154(4):278\u201384. https:\/\/doi.org\/10.1177\/17151635211014918.","journal-title":"Can Pharm J Ott"},{"issue":"6","key":"1637_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/a:1015142211348","volume":"23","author":"E Eide","year":"2001","unstructured":"Eide E, Schj\u00f8tt J. Assessing the effects of an intervention by a pharmacist on prescribing and administration of hypnotics in nursing homes. Pharm World Sci. 2001;23(6):227\u201331. https:\/\/doi.org\/10.1023\/a:1015142211348.","journal-title":"Pharm World Sci"},{"issue":"12","key":"1637_CR33","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1097\/JGP.0b013e3181d6c0c6","volume":"18","author":"DG Stevenson","year":"2010","unstructured":"Stevenson DG, Decker SL, Dwyer LL, et al. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psych. 2010;18(12):1078\u201392. https:\/\/doi.org\/10.1097\/JGP.0b013e3181d6c0c6.","journal-title":"Am J Geriatr Psych"},{"issue":"3","key":"1637_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00228-021-03244-4","volume":"78","author":"I Malagaris","year":"2022","unstructured":"Malagaris I, Mehta HB, Goodwin JS. Trends and variation in benzodiazepine use in nursing homes in the USA. Eur J Clin Pharmacol. 2022;78(3):489\u201396. https:\/\/doi.org\/10.1007\/s00228-021-03244-4.","journal-title":"Eur J Clin Pharmacol"},{"key":"1637_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40360-015-0019-8","volume":"16","author":"AS Pollmann","year":"2015","unstructured":"Pollmann AS, Murphy AL, Bergman JC, et al. Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacol Toxicol. 2015;16:19. https:\/\/doi.org\/10.1186\/s40360-015-0019-8.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"1637_CR36","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/fampra\/cmab017","volume":"38","author":"PRS Ribeiro","year":"2021","unstructured":"Ribeiro PRS, Schlindwein AD. Benzodiazepine deprescription strategies in chronic users: a systematic review. Fam Pract. 2021;38(5):684\u201393. https:\/\/doi.org\/10.1093\/fampra\/cmab017.","journal-title":"Fam Pract"},{"key":"1637_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13584-015-0045-4","volume":"4","author":"H Yariv","year":"2015","unstructured":"Yariv H. The case of pharmacist prescribing policy in Israel. Isr J Health Policy Res. 2015;4:49. https:\/\/doi.org\/10.1186\/s13584-015-0045-4.","journal-title":"Isr J Health Policy Res"},{"issue":"7","key":"1637_CR38","doi-asserted-by":"publisher","first-page":"e0214630","DOI":"10.1371\/journal.pone.0214630","volume":"14","author":"E Graham-Clarke","year":"2019","unstructured":"Graham-Clarke E et al. Non-medical prescribing in the United Kingdom National Health Service: a systematic policy review. PLoS ONE. 2019;14(7):e0214630. https:\/\/doi.org\/10.1371\/journal.pone.0214630.","journal-title":"PLoS ONE"},{"key":"1637_CR39","unstructured":"Conselho Federal de Farm\u00e1cia. (2013). Resolu\u00e7\u00e3o CFF n\u00ba 586, de 29 de agosto de 2013. Regula a prescri\u00e7\u00e3o farmac\u00eautica e d\u00e1 outras Provid\u00eancias. Di\u00e1rio Oficial da Uni\u00e3o, 29. Retrieved from: https:\/\/www.semesp.org.br\/wpcontent\/uploads\/2013\/09\/res_CFF_586-ok.pdf. Accessed 20 Jan 2023."},{"key":"1637_CR40","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1590\/1413-81232022279.19972021","volume":"27","author":"DC Ramos","year":"2022","unstructured":"Ramos DC et al. Pharmacist prescribing: a review of perceptions and attitudes of patients, pharmacists and other interested professionals. Ciencia saude coletiva. 2022;27:3531\u201346. https:\/\/doi.org\/10.1590\/1413-81232022279.19972021.","journal-title":"Ciencia saude coletiva."},{"issue":"1","key":"1637_CR41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1071\/AH14219","volume":"40","author":"A Mudge","year":"2016","unstructured":"Mudge A, Radnedge K, Kasper K, et al. Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing. Aust Health Rev. 2016;40(1):86\u201391. https:\/\/doi.org\/10.1071\/AH14219.","journal-title":"Aust Health Rev"},{"issue":"5","key":"1637_CR42","doi-asserted-by":"publisher","first-page":"705","DOI":"10.18433\/j37p5x","volume":"18","author":"M Sakakibara","year":"2015","unstructured":"Sakakibara M, Igarashi A, Takase Y, et al. Effects of prescription drug reduction on quality of life in community-dwelling patients with dementia. J Pharm Pharm Sci. 2015;18(5):705\u201312. https:\/\/doi.org\/10.18433\/j37p5x.","journal-title":"J Pharm Pharm Sci"},{"issue":"10","key":"1637_CR43","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.sapharm.2020.01.010","volume":"16","author":"AJ Cross","year":"2020","unstructured":"Cross AJ, George J, Woodward MC, et al. Deprescribing potentially inappropriate medications in memory clinic patients (DePIMM): a feasibility study. Res Social Adm Pharm. 2020;16(10):1392\u20137. https:\/\/doi.org\/10.1016\/j.sapharm.2020.01.010.","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"1637_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13012-022-01206-7","volume":"17","author":"P Evrard","year":"2022","unstructured":"Evrard P, P\u00e9tein C, Beuscart JB, et al. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework. Implement Sci. 2022;17(1):17\u201341. https:\/\/doi.org\/10.1186\/s13012-022-01206-7.","journal-title":"Implement Sci"},{"issue":"3","key":"1637_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjoq-2018-000539","volume":"8","author":"F Carr","year":"2019","unstructured":"Carr F, Tian P, Chow J, et al. Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative. BMJ Open Qual. 2019;8(3):1\u20138. https:\/\/doi.org\/10.1136\/bmjoq-2018-000539.","journal-title":"BMJ Open Qual"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01637-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-023-01637-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-023-01637-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:10:08Z","timestamp":1698228608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-023-01637-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1637"],"URL":"https:\/\/doi.org\/10.1007\/s11096-023-01637-2","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no potential conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}